GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) » Definitions » 6-1 Month Momentum %

Chengdu Olymvax Biopharmaceuticals (SHSE:688319) 6-1 Month Momentum % : 41.04% (As of May. 03, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Chengdu Olymvax Biopharmaceuticals 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2025-05-03), Chengdu Olymvax Biopharmaceuticals's 6-1 Month Momentum % is 41.04%.

The industry rank for Chengdu Olymvax Biopharmaceuticals's 6-1 Month Momentum % or its related term are showing as below:

SHSE:688319's 6-1 Month Momentum % is ranked better than
90.54% of 1470 companies
in the Biotechnology industry
Industry Median: -18.045 vs SHSE:688319: 41.04

Competitive Comparison of Chengdu Olymvax Biopharmaceuticals's 6-1 Month Momentum %

For the Biotechnology subindustry, Chengdu Olymvax Biopharmaceuticals's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chengdu Olymvax Biopharmaceuticals's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chengdu Olymvax Biopharmaceuticals's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Chengdu Olymvax Biopharmaceuticals's 6-1 Month Momentum % falls into.


;
;

Chengdu Olymvax Biopharmaceuticals  (SHSE:688319) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chengdu Olymvax Biopharmaceuticals  (SHSE:688319) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Chengdu Olymvax Biopharmaceuticals 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Chengdu Olymvax Biopharmaceuticals's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Chengdu Olymvax Biopharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
99 Tianxin Road, High-tech Zone, Sichuan Province, Chengdu, CHN, 611731
Chengdu Olymvax Biopharmaceuticals Inc is engaged in the research and development, production, and sales of human vaccines, focusing on innovative products.
Executives
Chen Dao Yuan Core technical personnel
Li Hong Guang Core technical personnel
Fan Shao Wen Directors, senior managers
Ma Heng Jun senior management
Wu Wei senior management
Fan Fan Director
Chen Ai Min Director
Tan Yong senior management
Lu Lu Director
Yu Yun Hui Director
Zhang Li Ying Core technical personnel
Chen Ke Ping Core technical personnel
Wu Qiang Core technical personnel
Yang Feng Core technical personnel

Chengdu Olymvax Biopharmaceuticals Headlines

No Headlines